BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiang C, Zhang ZH, Li JX. Consideration on immunotherapy of liver metastases of malignant tumors. World J Gastrointest Surg 2024; 16(8): 2374-2381 [PMID: 39220060 DOI: 10.4240/wjgs.v16.i8.2374]
URL: https://www.wjgnet.com/2307-8960/full/v16/i8/2374.htm
Number Citing Articles
1
Yi Zhu, Xiao Qi, Senmiao Ni, Wenting Qiu, Mengkai Chen. First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect ComparisonBiologics: Targets and Therapy 2026; : 1 doi: 10.2147/BTT.S602654
2
Noura A A Ebrahim, Thoraya A Farghaly, Ahmed Abdo El-Sherif, Ahmed M Fahmy, Moamen O Othman, Neveen S Tahoun, Omnia Mohamed Korany, Aya Arafat, Reham Oreaba, Soliman M A Soliman. Clinicopathological insights and management of liver metastases: Current advances and future perspectivesWorld Journal of Hepatology 2025; 17(10): 110026 doi: 10.4254/wjh.v17.i10.110026
3
Lin-Feng Guo, Guan-Zhong Lu, Zhen-Zhen Lu, Yi-Feng Yu, San-Gang Wu. Patterns of failure and prognosis in nasopharyngeal carcinoma according to Epstein-Barr virus DNA statusInfectious Agents and Cancer 2025; 20(1) doi: 10.1186/s13027-024-00631-1
4
Wenkai Kang, Zhiqiang Zhang, Wentao Li, Qingyuan Zhang, Ningning Li, Youheng Jiang, Junjing Zhang, Yulong He. Breaching the immune-cold barrier in pMMR/MSS metastatic colorectal cancer: emerging strategies beyond standard careFrontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1773002